Celgene psoriatic arthritis drug effective in trial
(Reuters) - Celgene Corp said on Thursday its experimental treatment for psoriatic arthritis was effective in a late-stage clinical trial, with no significant safety issues. The company said it expects to file for marketing approval of the drug, apremilast, in the first half of next year. Psoriatic arthritis is a chronic, inflammatory disease that affects the joints and causes pain, stiffness and swelling. It is associated with the skin disorder, psoriasis. ...
Source: news.yahoo.com
No comments:
Post a Comment